Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06044623
Title Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients (IMPORTANT)
Acronym IMPORTANT
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Region Orebro County
Indications
Therapies
Age Groups: senior
Covered Countries SWE | NOR | ITA | GRC | FIN | ESP


No variant requirements are available.